Search results for "Highlights"
New guidelines support probiotics for C. difficile prevention, but few other uses
The American Gastroenterological Association recommended that probiotics be used to treat patients with Clostridioides difficile infection, Crohn's disease, ulcerative colitis, or irritable bowel syndrome only in the context of a clinical trial.
https://gastroenterology.acponline.org/archives/2020/06/26/1.htm
26 Jun 2020
Liver function tests at admission could help predict mortality from COVID-19
Elevations in aspartate aminotransferase and direct bilirubin levels were significantly more common among patients in China who died of COVID-19 than those who survived to hospital discharge, a retrospective study found.
https://gastroenterology.acponline.org/archives/2021/01/22/1.htm
22 Jan 2021
Spotlight on ulcerative colitis
In the past month, the American Gastroenterological Association published new recommendations, a meta-analysis compared first- and second-line treatments, and a study found a recent decrease in colorectal cancer incidence in patients with ulcerative colitis.
https://gastroenterology.acponline.org/archives/2020/01/24/5.htm
24 Jan 2020
PPI use associated with more severe illness from COVID-19
A Korean cohort study did not find any association between use of proton-pump inhibitors (PPIs) and risk of infection with SARS-CoV-2, but current use was associated with higher risk of a composite endpoint that included ICU admission, mechanical ventilation, or death from COVID-19.
https://gastroenterology.acponline.org/archives/2020/08/28/1.htm
28 Aug 2020
Effects of gastric acid suppression drugs on COVID-19 outcomes still unclear
A meta-analysis didn't find an association between famotidine use and severe disease or death from COVID-19, and the association of these outcomes with proton-pump inhibitors varied by study type.
https://gastroenterology.acponline.org/archives/2021/02/26/1.htm
26 Feb 2021
Guideline recommends standardized management of mild to moderate ulcerative colitis
The guideline focuses on oral and topical 5-aminosalicylic acid medications, rectal corticosteroids, and oral budesonide in patients with mild to moderate disease.
https://gastroenterology.acponline.org/archives/2018/12/28/2.htm
28 Dec 2018
Previous gastroenteritis may be associated with later risk for IBD
In this Swedish case-control study, any previous GI infection and previous bacterial, parasitic, and viral GI infection were associated with higher risk for inflammatory bowel disease (IBD) versus controls.
https://gastroenterology.acponline.org/archives/2018/11/27/2.htm
27 Nov 2018
Individual or group hypnotherapy associated with relief from IBS
Although hypnotherapy did not improve quality of life, psychological symptoms, cognition, self-efficacy, or irritable bowel syndrome (IBS) symptoms significantly more than an educational support program, it may provide relief to patients by changing their perception of IBS.
https://gastroenterology.acponline.org/archives/2018/12/28/3.htm
28 Dec 2018
PPI prophylaxis didn't affect 90-day mortality rates among ICU patients
Gastrointestinal bleeds were less common among at-risk ICU patients who received IV pantoprazole instead of placebo, but rates of clinically important events were similar overall.
https://gastroenterology.acponline.org/archives/2018/10/26/2.htm
26 Oct 2018
Antidepressants may mitigate link between inflammatory bowel disease and depression
Patients with depression had more than double the risk of developing Crohn's disease or ulcerative colitis over a median follow-up of more than six years.
https://gastroenterology.acponline.org/archives/2018/10/26/3.htm
26 Oct 2018